SPY333.20-0.99 -0.30%
DIA274.89-1.02 -0.37%
IXIC11,111.12-6.40 -0.06%

Seattle Genetics Announces Submission Of Tucatinib New Drug Application To FDA For Patients With Locally Advanced Or Metastatic HER2-Positive Breast Cancer

Benzinga · 12/23/2019 13:07